Applied Therapeutics Inc (NQ: APLT )

5.850 -0.070 (-1.18%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist

Price and Volume

Volume	601,766
Open	5.920
Bid (Size)	5.780 (1)
Ask (Size)	5.950 (6)
Prev. Close	5.920
Today's Range	5.760 - 5.950
52wk Range	1.180 - 9.390
Shares Outstanding	114,846,271
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Applied Therapeutics Reports Second Quarter 2024 Financial Results

August 07, 2024

From Applied Therapeutics

Via GlobeNewswire

Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside

July 31, 2024

William Blair has initiated coverage on Applied Therapeutics highlighting its focus on rare diseases such as galactosemia, SORD deficiency, and diabetic cardiomyopathy. With govorestat (AT-007) poised...

Via Benzinga

Performance

YTD	+60.71%	+60.71%
1 Month	+3.91%	+3.91%
3 Month	+37.65%	+37.65%
6 Month	+56.00%	+56.00%
1 Year	+357.03%	+357.03%

More News

CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

July 16, 2024

Via Benzinga

Applied Therapeutics Added to Russell 3000® Index

July 01, 2024

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics: Q4 Earnings Insights

March 06, 2024

Via Benzinga

Top 4 Health Care Stocks That May Keep You Up At Night This Month

June 11, 2024

Via Benzinga

APLT Stock Earnings: Applied Therapeutics Meets EPS, Misses Revenue for Q1 2024

May 09, 2024

Via InvestorPlace

Applied Therapeutics Reports First Quarter 2024 Financial Results

May 09, 2024

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference

May 07, 2024

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer

April 15, 2024

From Applied Therapeutics

Via GlobeNewswire

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024

April 04, 2024

From Applied Therapeutics

Via GlobeNewswire

FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease

April 01, 2024

Via Benzinga

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket

April 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session

April 01, 2024

Via Benzinga

Oxford Industries Posts Weak Results, Joins Applied Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

April 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session

March 29, 2024

Via Benzinga

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

March 28, 2024

From Applied Therapeutics

Via GlobeNewswire

EQT, Genie Energy And Other Big Stocks Moving Lower On Monday

March 11, 2024

Via Benzinga

Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results

March 06, 2024

From Applied Therapeutics

Via GlobeNewswire

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

February 28, 2024

Via Benzinga

Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday

February 28, 2024

Via Benzinga

FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder

February 28, 2024

Via Benzinga

Why Is Coupang (CPNG) Stock Up 4% Today?

February 28, 2024

Via InvestorPlace

Applied Therapeutics Inc. (NASDAQ: APLT) Records 52-Week High Wednesday Morning

February 28, 2024

Via Investor Brand Network

Why Is Applied Therapeutics (APLT) Stock Up 59% Today?

February 28, 2024

Via InvestorPlace

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.